Literature DB >> 21151202

Lysine methylation of promoter-bound transcription factors and relevance to cancer.

George R Stark1, Yuxin Wang, Tao Lu.   

Abstract

p53, NFκB, STAT3, and several other transcription factors are reversibly methylated on lysine residues by enzymes that also modify histones. The methylations of NFκB and STAT3 take place when they are bound to promoters, suggesting a more general model in which the binding of inducible transcription factors to DNA helps to recruit chromatin-modification machinery, which then may modify not only histones but also the bound transcription factors. Mutations of some histone-lysine methyltransferases and demethylases are linked to cancer, and these mutations may alter the methylation not only of histones but also of transcription factors, and thus may be tumorigenic through more than one mechanism.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21151202      PMCID: PMC3193425          DOI: 10.1038/cr.2010.174

Source DB:  PubMed          Journal:  Cell Res        ISSN: 1001-0602            Impact factor:   25.617


  57 in total

1.  Negative regulation of NF-kappaB action by Set9-mediated lysine methylation of the RelA subunit.

Authors:  Xiao-Dong Yang; Bo Huang; Mingxi Li; Acacia Lamb; Neil L Kelleher; Lin-Feng Chen
Journal:  EMBO J       Date:  2009-03-05       Impact factor: 11.598

2.  Mutations of ASXL1 gene in myeloproliferative neoplasms.

Authors:  N Carbuccia; A Murati; V Trouplin; M Brecqueville; J Adélaïde; J Rey; W Vainchenker; O A Bernard; M Chaffanet; N Vey; D Birnbaum; M J Mozziconacci
Journal:  Leukemia       Date:  2009-07-16       Impact factor: 11.528

Review 3.  Protein acetylation in the cardiorenal axis: the promise of histone deacetylase inhibitors.

Authors:  Erik W Bush; Timothy A McKinsey
Journal:  Circ Res       Date:  2010-02-05       Impact factor: 17.367

4.  The histone demethylase UTX enables RB-dependent cell fate control.

Authors:  Jordon K Wang; Miao-Chih Tsai; Gino Poulin; Adam S Adler; Shuzhen Chen; Helen Liu; Yang Shi; Howard Y Chang
Journal:  Genes Dev       Date:  2010-02-01       Impact factor: 11.361

5.  Regulation of NF-kappaB by NSD1/FBXL11-dependent reversible lysine methylation of p65.

Authors:  Tao Lu; Mark W Jackson; Benlian Wang; Maojing Yang; Mark R Chance; Masaru Miyagi; Andrei V Gudkov; George R Stark
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-22       Impact factor: 11.205

6.  ASXL1 represses retinoic acid receptor-mediated transcription through associating with HP1 and LSD1.

Authors:  Sang-Wang Lee; Yang-Sook Cho; Jung-Min Na; Ui-Hyun Park; Myengmo Kang; Eun-Joo Kim; Soo-Jong Um
Journal:  J Biol Chem       Date:  2009-10-31       Impact factor: 5.157

7.  Regulation of NF-kappaB activity through lysine monomethylation of p65.

Authors:  Chee-Kwee Ea; David Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-28       Impact factor: 11.205

Review 8.  Histone methyltransferases in cancer.

Authors:  Mareike Albert; Kristian Helin
Journal:  Semin Cell Dev Biol       Date:  2009-11-03       Impact factor: 7.727

Review 9.  The emerging characterization of lysine residue deacetylation on the modulation of mitochondrial function and cardiovascular biology.

Authors:  Zhongping Lu; Iain Scott; Bradley R Webster; Michael N Sack
Journal:  Circ Res       Date:  2009-10-23       Impact factor: 17.367

10.  Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer.

Authors:  Gijs van Haaften; Gillian L Dalgliesh; Helen Davies; Lina Chen; Graham Bignell; Chris Greenman; Sarah Edkins; Claire Hardy; Sarah O'Meara; Jon Teague; Adam Butler; Jonathan Hinton; Calli Latimer; Jenny Andrews; Syd Barthorpe; Dave Beare; Gemma Buck; Peter J Campbell; Jennifer Cole; Simon Forbes; Mingming Jia; David Jones; Chai Yin Kok; Catherine Leroy; Meng-Lay Lin; David J McBride; Mark Maddison; Simon Maquire; Kirsten McLay; Andrew Menzies; Tatiana Mironenko; Lee Mulderrig; Laura Mudie; Erin Pleasance; Rebecca Shepherd; Raffaella Smith; Lucy Stebbings; Philip Stephens; Gurpreet Tang; Patrick S Tarpey; Rachel Turner; Kelly Turrell; Jennifer Varian; Sofie West; Sara Widaa; Paul Wray; V Peter Collins; Koichi Ichimura; Simon Law; John Wong; Siu Tsan Yuen; Suet Yi Leung; Giovanni Tonon; Ronald A DePinho; Yu-Tzu Tai; Kenneth C Anderson; Richard J Kahnoski; Aaron Massie; Sok Kean Khoo; Bin Tean Teh; Michael R Stratton; P Andrew Futreal
Journal:  Nat Genet       Date:  2009-03-29       Impact factor: 38.330

View more
  36 in total

Review 1.  Regulation of transcription factor activity by interconnected post-translational modifications.

Authors:  Theresa M Filtz; Walter K Vogel; Mark Leid
Journal:  Trends Pharmacol Sci       Date:  2013-12-30       Impact factor: 14.819

2.  Noncanonical STAT3 activation regulates excess TGF-β1 and collagen I expression in muscle of stricturing Crohn's disease.

Authors:  Chao Li; Audra Iness; Jennifer Yoon; John R Grider; Karnam S Murthy; John M Kellum; John F Kuemmerle
Journal:  J Immunol       Date:  2015-03-04       Impact factor: 5.422

3.  PRMT5 dimethylates R30 of the p65 subunit to activate NF-κB.

Authors:  Han Wei; Benlian Wang; Masaru Miyagi; Yun She; Banu Gopalan; De-Bin Huang; Gourisankar Ghosh; George R Stark; Tao Lu
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-31       Impact factor: 11.205

4.  Role of lysine methylation of NF-κB in differential gene regulation.

Authors:  Tao Lu; Maojing Yang; De-Bin Huang; Han Wei; Gulcin H Ozer; Gourisankar Ghosh; George R Stark
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-31       Impact factor: 11.205

5.  The regulatory proteins DSCR6 and Ezh2 oppositely regulate Stat3 transcriptional activity in mesoderm patterning during Xenopus development.

Authors:  Mafalda Loreti; De-Li Shi; Clémence Carron
Journal:  J Biol Chem       Date:  2020-01-29       Impact factor: 5.157

6.  Cell signaling, post-translational protein modifications and NMR spectroscopy.

Authors:  Francois-Xavier Theillet; Caroline Smet-Nocca; Stamatios Liokatis; Rossukon Thongwichian; Jonas Kosten; Mi-Kyung Yoon; Richard W Kriwacki; Isabelle Landrieu; Guy Lippens; Philipp Selenko
Journal:  J Biomol NMR       Date:  2012-09-26       Impact factor: 2.835

7.  STAT3-driven transcription depends upon the dimethylation of K49 by EZH2.

Authors:  Maupali Dasgupta; Josephine Kam Tai Dermawan; Belinda Willard; George R Stark
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-12       Impact factor: 11.205

8.  Phosphorylation of EZH2 activates STAT3 signaling via STAT3 methylation and promotes tumorigenicity of glioblastoma stem-like cells.

Authors:  Eunhee Kim; Misuk Kim; Dong-Hun Woo; Yongjae Shin; Jihye Shin; Nakho Chang; Young Taek Oh; Hong Kim; Jingeun Rheey; Ichiro Nakano; Cheolju Lee; Kyeung Min Joo; Jeremy N Rich; Do-Hyun Nam; Jeongwu Lee
Journal:  Cancer Cell       Date:  2013-05-16       Impact factor: 31.743

Review 9.  NF-κB: Regulation by Methylation.

Authors:  Tao Lu; George R Stark
Journal:  Cancer Res       Date:  2015-09-03       Impact factor: 12.701

Review 10.  Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 to Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution.

Authors:  Uddalak Bharadwaj; Moses M Kasembeli; Prema Robinson; David J Tweardy
Journal:  Pharmacol Rev       Date:  2020-04       Impact factor: 25.468

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.